An insulin pump is a medical device used for the administration of insulin in the treatment of diabetes mellitus, also known as continuous subcutaneous insulin infusion therapy. The device configuration may vary depending on design. A traditional pump includes: the pump (including controls, processing module, and batteries); a disposable reservoir for insulin (inside the pump) a disposable infusion set, including a cannula for subcutaneous insertion (under the skin) and a tubing system to interface the insulin reservoir to the cannula. Other configurations are possible. For instance, more recent models may include disposable or semi-disposable designs for the pumping mechanism and may eliminate tubing from the infusion set.
This report aims to provide a comprehensive presentation of the global market for Continuous Subcutaneous Insulin Infusion Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Continuous Subcutaneous Insulin Infusion Therapy. This report contains market size and forecasts of Continuous Subcutaneous Insulin Infusion Therapy in global, including the following market information:
Global Continuous Subcutaneous Insulin Infusion Therapy Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global top five companies in 2022 (%)
The global Continuous Subcutaneous Insulin Infusion Therapy market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Normal Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Continuous Subcutaneous Insulin Infusion Therapy include Medtronic, Roche, SOOIL, Tandem Diabetes care, Insulet Corp, Valeritas and Microport, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Continuous Subcutaneous Insulin Infusion Therapy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Continuous Subcutaneous Insulin Infusion Therapy Market, by Type, 2018-2023, 2024-2030 ($ millions)
Global Continuous Subcutaneous Insulin Infusion Therapy Market Segment Percentages, by Type, 2022 (%)
Normal
Patch Pump
Global Continuous Subcutaneous Insulin Infusion Therapy Market, by Application, 2018-2023, 2024-2030 ($ millions)
Global Continuous Subcutaneous Insulin Infusion Therapy Market Segment Percentages, by Application, 2022 (%)
Hospital
Retail Pharmacy
Other
Global Continuous Subcutaneous Insulin Infusion Therapy Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions)
Global Continuous Subcutaneous Insulin Infusion Therapy Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Continuous Subcutaneous Insulin Infusion Therapy revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Continuous Subcutaneous Insulin Infusion Therapy revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Medtronic
Roche
SOOIL
Tandem Diabetes care
Insulet Corp
Valeritas
Microport
Outline of Major Chapters:
Chapter 1: Introduces the definition of Continuous Subcutaneous Insulin Infusion Therapy, market overview.
Chapter 2: Global Continuous Subcutaneous Insulin Infusion Therapy market size in revenue.
Chapter 3: Detailed analysis of Continuous Subcutaneous Insulin Infusion Therapy company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Continuous Subcutaneous Insulin Infusion Therapy in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Continuous Subcutaneous Insulin Infusion Therapy Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Continuous Subcutaneous Insulin Infusion Therapy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Continuous Subcutaneous Insulin Infusion Therapy Overall Market Size
2.1 Global Continuous Subcutaneous Insulin Infusion Therapy Market Size: 2022 VS 2030
2.2 Global Continuous Subcutaneous Insulin Infusion Therapy Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Continuous Subcutaneous Insulin Infusion Therapy Players in Global Market
3.2 Top Global Continuous Subcutaneous Insulin Infusion Therapy Companies Ranked by Revenue
3.3 Global Continuous Subcutaneous Insulin Infusion Therapy Revenue by Companies
3.4 Top 3 and Top 5 Continuous Subcutaneous Insulin Infusion Therapy Companies in Global Market, by Revenue in 2022
3.5 Global Companies Continuous Subcutaneous Insulin Infusion Therapy Product Type
3.6 Tier 1, Tier 2 and Tier 3 Continuous Subcutaneous Insulin Infusion Therapy Players in Global Market
3.6.1 List of Global Tier 1 Continuous Subcutaneous Insulin Infusion Therapy Companies
3.6.2 List of Global Tier 2 and Tier 3 Continuous Subcutaneous Insulin Infusion Therapy Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Continuous Subcutaneous Insulin Infusion Therapy Market Size Markets, 2022 & 2030
4.1.2 Normal
4.1.3 Patch Pump
4.2 By Type - Global Continuous Subcutaneous Insulin Infusion Therapy Revenue & Forecasts
4.2.1 By Type - Global Continuous Subcutaneous Insulin Infusion Therapy Revenue, 2018-2023
4.2.2 By Type - Global Continuous Subcutaneous Insulin Infusion Therapy Revenue, 2024-2030
4.2.3 By Type - Global Continuous Subcutaneous Insulin Infusion Therapy Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Continuous Subcutaneous Insulin Infusion Therapy Market Size, 2022 & 2030
5.1.2 Hospital
5.1.3 Retail Pharmacy
5.1.4 Other
5.2 By Application - Global Continuous Subcutaneous Insulin Infusion Therapy Revenue & Forecasts
5.2.1 By Application - Global Continuous Subcutaneous Insulin Infusion Therapy Revenue, 2018-2023
5.2.2 By Application - Global Continuous Subcutaneous Insulin Infusion Therapy Revenue, 2024-2030
5.2.3 By Application - Global Continuous Subcutaneous Insulin Infusion Therapy Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Continuous Subcutaneous Insulin Infusion Therapy Market Size, 2022 & 2030
6.2 By Region - Global Continuous Subcutaneous Insulin Infusion Therapy Revenue & Forecasts
6.2.1 By Region - Global Continuous Subcutaneous Insulin Infusion Therapy Revenue, 2018-2023
6.2.2 By Region - Global Continuous Subcutaneous Insulin Infusion Therapy Revenue, 2024-2030
6.2.3 By Region - Global Continuous Subcutaneous Insulin Infusion Therapy Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Continuous Subcutaneous Insulin Infusion Therapy Revenue, 2018-2030
6.3.2 US Continuous Subcutaneous Insulin Infusion Therapy Market Size, 2018-2030
6.3.3 Canada Continuous Subcutaneous Insulin Infusion Therapy Market Size, 2018-2030
6.3.4 Mexico Continuous Subcutaneous Insulin Infusion Therapy Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Continuous Subcutaneous Insulin Infusion Therapy Revenue, 2018-2030
6.4.2 Germany Continuous Subcutaneous Insulin Infusion Therapy Market Size, 2018-2030
6.4.3 France Continuous Subcutaneous Insulin Infusion Therapy Market Size, 2018-2030
6.4.4 U.K. Continuous Subcutaneous Insulin Infusion Therapy Market Size, 2018-2030
6.4.5 Italy Continuous Subcutaneous Insulin Infusion Therapy Market Size, 2018-2030
6.4.6 Russia Continuous Subcutaneous Insulin Infusion Therapy Market Size, 2018-2030
6.4.7 Nordic Countries Continuous Subcutaneous Insulin Infusion Therapy Market Size, 2018-2030
6.4.8 Benelux Continuous Subcutaneous Insulin Infusion Therapy Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Continuous Subcutaneous Insulin Infusion Therapy Revenue, 2018-2030
6.5.2 China Continuous Subcutaneous Insulin Infusion Therapy Market Size, 2018-2030
6.5.3 Japan Continuous Subcutaneous Insulin Infusion Therapy Market Size, 2018-2030
6.5.4 South Korea Continuous Subcutaneous Insulin Infusion Therapy Market Size, 2018-2030
6.5.5 Southeast Asia Continuous Subcutaneous Insulin Infusion Therapy Market Size, 2018-2030
6.5.6 India Continuous Subcutaneous Insulin Infusion Therapy Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Continuous Subcutaneous Insulin Infusion Therapy Revenue, 2018-2030
6.6.2 Brazil Continuous Subcutaneous Insulin Infusion Therapy Market Size, 2018-2030
6.6.3 Argentina Continuous Subcutaneous Insulin Infusion Therapy Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Continuous Subcutaneous Insulin Infusion Therapy Revenue, 2018-2030
6.7.2 Turkey Continuous Subcutaneous Insulin Infusion Therapy Market Size, 2018-2030
6.7.3 Israel Continuous Subcutaneous Insulin Infusion Therapy Market Size, 2018-2030
6.7.4 Saudi Arabia Continuous Subcutaneous Insulin Infusion Therapy Market Size, 2018-2030
6.7.5 UAE Continuous Subcutaneous Insulin Infusion Therapy Market Size, 2018-2030
7 Continuous Subcutaneous Insulin Infusion Therapy Companies Profiles
7.1 Medtronic
7.1.1 Medtronic Company Summary
7.1.2 Medtronic Business Overview
7.1.3 Medtronic Continuous Subcutaneous Insulin Infusion Therapy Major Product Offerings
7.1.4 Medtronic Continuous Subcutaneous Insulin Infusion Therapy Revenue in Global Market (2018-2023)
7.1.5 Medtronic Key News & Latest Developments
7.2 Roche
7.2.1 Roche Company Summary
7.2.2 Roche Business Overview
7.2.3 Roche Continuous Subcutaneous Insulin Infusion Therapy Major Product Offerings
7.2.4 Roche Continuous Subcutaneous Insulin Infusion Therapy Revenue in Global Market (2018-2023)
7.2.5 Roche Key News & Latest Developments
7.3 SOOIL
7.3.1 SOOIL Company Summary
7.3.2 SOOIL Business Overview
7.3.3 SOOIL Continuous Subcutaneous Insulin Infusion Therapy Major Product Offerings
7.3.4 SOOIL Continuous Subcutaneous Insulin Infusion Therapy Revenue in Global Market (2018-2023)
7.3.5 SOOIL Key News & Latest Developments
7.4 Tandem Diabetes care
7.4.1 Tandem Diabetes care Company Summary
7.4.2 Tandem Diabetes care Business Overview
7.4.3 Tandem Diabetes care Continuous Subcutaneous Insulin Infusion Therapy Major Product Offerings
7.4.4 Tandem Diabetes care Continuous Subcutaneous Insulin Infusion Therapy Revenue in Global Market (2018-2023)
7.4.5 Tandem Diabetes care Key News & Latest Developments
7.5 Insulet Corp
7.5.1 Insulet Corp Company Summary
7.5.2 Insulet Corp Business Overview
7.5.3 Insulet Corp Continuous Subcutaneous Insulin Infusion Therapy Major Product Offerings
7.5.4 Insulet Corp Continuous Subcutaneous Insulin Infusion Therapy Revenue in Global Market (2018-2023)
7.5.5 Insulet Corp Key News & Latest Developments
7.6 Valeritas
7.6.1 Valeritas Company Summary
7.6.2 Valeritas Business Overview
7.6.3 Valeritas Continuous Subcutaneous Insulin Infusion Therapy Major Product Offerings
7.6.4 Valeritas Continuous Subcutaneous Insulin Infusion Therapy Revenue in Global Market (2018-2023)
7.6.5 Valeritas Key News & Latest Developments
7.7 Microport
7.7.1 Microport Company Summary
7.7.2 Microport Business Overview
7.7.3 Microport Continuous Subcutaneous Insulin Infusion Therapy Major Product Offerings
7.7.4 Microport Continuous Subcutaneous Insulin Infusion Therapy Revenue in Global Market (2018-2023)
7.7.5 Microport Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Continuous Subcutaneous Insulin Infusion Therapy Market Opportunities & Trends in Global Market
Table 2. Continuous Subcutaneous Insulin Infusion Therapy Market Drivers in Global Market
Table 3. Continuous Subcutaneous Insulin Infusion Therapy Market Restraints in Global Market
Table 4. Key Players of Continuous Subcutaneous Insulin Infusion Therapy in Global Market
Table 5. Top Continuous Subcutaneous Insulin Infusion Therapy Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Continuous Subcutaneous Insulin Infusion Therapy Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Continuous Subcutaneous Insulin Infusion Therapy Revenue Share by Companies, 2018-2023
Table 8. Global Companies Continuous Subcutaneous Insulin Infusion Therapy Product Type
Table 9. List of Global Tier 1 Continuous Subcutaneous Insulin Infusion Therapy Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Continuous Subcutaneous Insulin Infusion Therapy Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Continuous Subcutaneous Insulin Infusion Therapy Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Continuous Subcutaneous Insulin Infusion Therapy Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Continuous Subcutaneous Insulin Infusion Therapy Revenue in Global (US$, Mn), 2024-2030
Table 14. By Application ? Global Continuous Subcutaneous Insulin Infusion Therapy Revenue, (US$, Mn), 2022 & 2030
Table 15. By Application - Continuous Subcutaneous Insulin Infusion Therapy Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Continuous Subcutaneous Insulin Infusion Therapy Revenue in Global (US$, Mn), 2024-2030
Table 17. By Region ? Global Continuous Subcutaneous Insulin Infusion Therapy Revenue, (US$, Mn), 2022 & 2030
Table 18. By Region - Global Continuous Subcutaneous Insulin Infusion Therapy Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Continuous Subcutaneous Insulin Infusion Therapy Revenue (US$, Mn), 2024-2030
Table 20. By Country - North America Continuous Subcutaneous Insulin Infusion Therapy Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Continuous Subcutaneous Insulin Infusion Therapy Revenue, (US$, Mn), 2024-2030
Table 22. By Country - Europe Continuous Subcutaneous Insulin Infusion Therapy Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Continuous Subcutaneous Insulin Infusion Therapy Revenue, (US$, Mn), 2024-2030
Table 24. By Region - Asia Continuous Subcutaneous Insulin Infusion Therapy Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Continuous Subcutaneous Insulin Infusion Therapy Revenue, (US$, Mn), 2024-2030
Table 26. By Country - South America Continuous Subcutaneous Insulin Infusion Therapy Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Continuous Subcutaneous Insulin Infusion Therapy Revenue, (US$, Mn), 2024-2030
Table 28. By Country - Middle East & Africa Continuous Subcutaneous Insulin Infusion Therapy Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Continuous Subcutaneous Insulin Infusion Therapy Revenue, (US$, Mn), 2024-2030
Table 30. Medtronic Company Summary
Table 31. Medtronic Continuous Subcutaneous Insulin Infusion Therapy Product Offerings
Table 32. Medtronic Continuous Subcutaneous Insulin Infusion Therapy Revenue (US$, Mn) & (2018-2023)
Table 33. Medtronic Key News & Latest Developments
Table 34. Roche Company Summary
Table 35. Roche Continuous Subcutaneous Insulin Infusion Therapy Product Offerings
Table 36. Roche Continuous Subcutaneous Insulin Infusion Therapy Revenue (US$, Mn) & (2018-2023)
Table 37. Roche Key News & Latest Developments
Table 38. SOOIL Company Summary
Table 39. SOOIL Continuous Subcutaneous Insulin Infusion Therapy Product Offerings
Table 40. SOOIL Continuous Subcutaneous Insulin Infusion Therapy Revenue (US$, Mn) & (2018-2023)
Table 41. SOOIL Key News & Latest Developments
Table 42. Tandem Diabetes care Company Summary
Table 43. Tandem Diabetes care Continuous Subcutaneous Insulin Infusion Therapy Product Offerings
Table 44. Tandem Diabetes care Continuous Subcutaneous Insulin Infusion Therapy Revenue (US$, Mn) & (2018-2023)
Table 45. Tandem Diabetes care Key News & Latest Developments
Table 46. Insulet Corp Company Summary
Table 47. Insulet Corp Continuous Subcutaneous Insulin Infusion Therapy Product Offerings
Table 48. Insulet Corp Continuous Subcutaneous Insulin Infusion Therapy Revenue (US$, Mn) & (2018-2023)
Table 49. Insulet Corp Key News & Latest Developments
Table 50. Valeritas Company Summary
Table 51. Valeritas Continuous Subcutaneous Insulin Infusion Therapy Product Offerings
Table 52. Valeritas Continuous Subcutaneous Insulin Infusion Therapy Revenue (US$, Mn) & (2018-2023)
Table 53. Valeritas Key News & Latest Developments
Table 54. Microport Company Summary
Table 55. Microport Continuous Subcutaneous Insulin Infusion Therapy Product Offerings
Table 56. Microport Continuous Subcutaneous Insulin Infusion Therapy Revenue (US$, Mn) & (2018-2023)
Table 57. Microport Key News & Latest Developments
List of Figures
Figure 1. Continuous Subcutaneous Insulin Infusion Therapy Segment by Type in 2022
Figure 2. Continuous Subcutaneous Insulin Infusion Therapy Segment by Application in 2022
Figure 3. Global Continuous Subcutaneous Insulin Infusion Therapy Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Continuous Subcutaneous Insulin Infusion Therapy Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Continuous Subcutaneous Insulin Infusion Therapy Revenue, 2018-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Continuous Subcutaneous Insulin Infusion Therapy Revenue in 2022
Figure 8. By Type - Global Continuous Subcutaneous Insulin Infusion Therapy Revenue Market Share, 2018-2030
Figure 9. By Application - Global Continuous Subcutaneous Insulin Infusion Therapy Revenue Market Share, 2018-2030
Figure 10. By Type - Global Continuous Subcutaneous Insulin Infusion Therapy Revenue, (US$, Mn), 2022 & 2030
Figure 11. By Type - Global Continuous Subcutaneous Insulin Infusion Therapy Revenue Market Share, 2018-2030
Figure 12. By Application - Global Continuous Subcutaneous Insulin Infusion Therapy Revenue, (US$, Mn), 2022 & 2030
Figure 13. By Application - Global Continuous Subcutaneous Insulin Infusion Therapy Revenue Market Share, 2018-2030
Figure 14. By Region - Global Continuous Subcutaneous Insulin Infusion Therapy Revenue Market Share, 2018-2030
Figure 15. By Country - North America Continuous Subcutaneous Insulin Infusion Therapy Revenue Market Share, 2018-2030
Figure 16. US Continuous Subcutaneous Insulin Infusion Therapy Revenue, (US$, Mn), 2018-2030
Figure 17. Canada Continuous Subcutaneous Insulin Infusion Therapy Revenue, (US$, Mn), 2018-2030
Figure 18. Mexico Continuous Subcutaneous Insulin Infusion Therapy Revenue, (US$, Mn), 2018-2030
Figure 19. By Country - Europe Continuous Subcutaneous Insulin Infusion Therapy Revenue Market Share, 2018-2030
Figure 20. Germany Continuous Subcutaneous Insulin Infusion Therapy Revenue, (US$, Mn), 2018-2030
Figure 21. France Continuous Subcutaneous Insulin Infusion Therapy Revenue, (US$, Mn), 2018-2030
Figure 22. U.K. Continuous Subcutaneous Insulin Infusion Therapy Revenue, (US$, Mn), 2018-2030
Figure 23. Italy Continuous Subcutaneous Insulin Infusion Therapy Revenue, (US$, Mn), 2018-2030
Figure 24. Russia Continuous Subcutaneous Insulin Infusion Therapy Revenue, (US$, Mn), 2018-2030
Figure 25. Nordic Countries Continuous Subcutaneous Insulin Infusion Therapy Revenue, (US$, Mn), 2018-2030
Figure 26. Benelux Continuous Subcutaneous Insulin Infusion Therapy Revenue, (US$, Mn), 2018-2030
Figure 27. By Region - Asia Continuous Subcutaneous Insulin Infusion Therapy Revenue Market Share, 2018-2030
Figure 28. China Continuous Subcutaneous Insulin Infusion Therapy Revenue, (US$, Mn), 2018-2030
Figure 29. Japan Continuous Subcutaneous Insulin Infusion Therapy Revenue, (US$, Mn), 2018-2030
Figure 30. South Korea Continuous Subcutaneous Insulin Infusion Therapy Revenue, (US$, Mn), 2018-2030
Figure 31. Southeast Asia Continuous Subcutaneous Insulin Infusion Therapy Revenue, (US$, Mn), 2018-2030
Figure 32. India Continuous Subcutaneous Insulin Infusion Therapy Revenue, (US$, Mn), 2018-2030
Figure 33. By Country - South America Continuous Subcutaneous Insulin Infusion Therapy Revenue Market Share, 2018-2030
Figure 34. Brazil Continuous Subcutaneous Insulin Infusion Therapy Revenue, (US$, Mn), 2018-2030
Figure 35. Argentina Continuous Subcutaneous Insulin Infusion Therapy Revenue, (US$, Mn), 2018-2030
Figure 36. By Country - Middle East & Africa Continuous Subcutaneous Insulin Infusion Therapy Revenue Market Share, 2018-2030
Figure 37. Turkey Continuous Subcutaneous Insulin Infusion Therapy Revenue, (US$, Mn), 2018-2030
Figure 38. Israel Continuous Subcutaneous Insulin Infusion Therapy Revenue, (US$, Mn), 2018-2030
Figure 39. Saudi Arabia Continuous Subcutaneous Insulin Infusion Therapy Revenue, (US$, Mn), 2018-2030
Figure 40. UAE Continuous Subcutaneous Insulin Infusion Therapy Revenue, (US$, Mn), 2018-2030
Figure 41. Medtronic Continuous Subcutaneous Insulin Infusion Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Roche Continuous Subcutaneous Insulin Infusion Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. SOOIL Continuous Subcutaneous Insulin Infusion Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Tandem Diabetes care Continuous Subcutaneous Insulin Infusion Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Insulet Corp Continuous Subcutaneous Insulin Infusion Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Valeritas Continuous Subcutaneous Insulin Infusion Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Microport Continuous Subcutaneous Insulin Infusion Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
